KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

West Pharmaceutical Services (WST) Equity Ratio (2016 - 2025)

Historic Equity Ratio for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to 0.74.

  • West Pharmaceutical Services' Equity Ratio rose 103.04% to 0.74 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.74, marking a year-over-year increase of 103.04%. This contributed to the annual value of 0.74 for FY2025, which is 103.04% up from last year.
  • As of Q4 2025, West Pharmaceutical Services' Equity Ratio stood at 0.74, which was up 103.04% from 0.74 recorded in Q3 2025.
  • Over the past 5 years, West Pharmaceutical Services' Equity Ratio peaked at 0.76 during Q3 2023, and registered a low of 0.67 during Q1 2021.
  • For the 5-year period, West Pharmaceutical Services' Equity Ratio averaged around 0.73, with its median value being 0.74 (2022).
  • As far as peak fluctuations go, West Pharmaceutical Services' Equity Ratio skyrocketed by 629.94% in 2022, and later plummeted by 214.13% in 2024.
  • West Pharmaceutical Services' Equity Ratio (Quarter) stood at 0.7 in 2021, then rose by 5.33% to 0.74 in 2022, then grew by 1.34% to 0.75 in 2023, then dropped by 2.14% to 0.74 in 2024, then rose by 1.03% to 0.74 in 2025.
  • Its last three reported values are 0.74 in Q4 2025, 0.74 for Q3 2025, and 0.74 during Q2 2025.